“Bimekizumab Efficacy through One Year in Patients With Moderate to Severe Plaque Psoriasis in Subgroups Defined by Prior Biologic Treatment: Pooled Results from Four Phase 3 3b Trials ”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s64. https://doi.org/10.25251/skin.6.supp.64.